Full Info:

Resource Type:

Webinar

Citation:

This webinar in the “Let’s Talk MPTs” discussion series was held in partnership between the Initiative for MPTs (IMPT) and Microbicide R&D to Advance HIV Prevention Technologies through Responsive Innovation and eXcellence (MATRIX). The webinar provides a valuable opportunity to hear from MPT and HIV prevention product developers and other experts on the following topics related to intellectual property and patenting considerations necessary for bringing MPTs and HIV prevention products to market:

• Patent protection
• Accessing APIs
• Freedom to operate
• Royalties Tech transfer

Featured speakers included Ian McGowan from Orion Biotechnology, Nataliya Omelchuk from Medicines Patent Pool, and Akash Bakshi from YourChoice Therapeutics.

Authors: The IMPT, Ian McGowan, Nataliya Omelchuk, Akash Bakshi

Health Risks(s):

• HIV
• STI / STD
• Unintended Pregnancy

Product type(s):

• MPTs

Topic(s):

• MPTs
• Development

Region(s)

• Global

Additional Keywords:

Patenting, Intellectual Property